Heart Failure with Mildly Reduced Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Mildly Reduced Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity [Phase 3]
A Phase 3 trial evaluating Maridebart Cafraglutide for heart failure with preserved or mildly reduced ejection fraction in people with obesi…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program
This clinical trial update reports the completion of a national telemonitoring program evaluating the use of SGLT2 inhibitors in heart failu…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) [Phase 1]
Phase 1 safety and tolerability study of XXB750 in heart failure patients with reduced or mildly reduced ejection fraction has been complete…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Frailty and Outcomes in Older Heart Failure Patients With Ejection Fraction >40%
An update on an ongoing clinical trial evaluating frailty and outcomes in older heart failure patients with EF >40%, covering heart failure …
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction
This clinical trial evaluated iron deficiency in patients with heart failure with reduced ejection fraction (HFrEF) and heart failure with m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.